These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9034960)

  • 1. Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibition.
    Binisti C; Touboul E; Mounier C; Heymans F; Bon C; Godfroid JJ
    J Lipid Mediat Cell Signal; 1997 Jan; 15(2):125-44. PubMed ID: 9034960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines.
    Binisti C; Assogba L; Touboul E; Mounier C; Huet J; Ombetta JE; Dong CZ; Redeuilh C; Heymans F; Godfroid JJ
    Eur J Med Chem; 2001 Oct; 36(10):809-28. PubMed ID: 11738488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new phospholipase A2 inhibitor, unrelated to substrate analogues: kinetic characterization of the inhibition of secretory phospholipases A2 by PMS 832.
    Binisti C; Mounier C; Touboul E; Heymans F; Bon C; Godfroid JJ
    J Lipid Mediat Cell Signal; 1997 Jul; 16(3):171-87. PubMed ID: 9246606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors.
    Aitdafoun M; Mounier C; Heymans F; Binisti C; Bon C; Godfroid JJ
    Biochem Pharmacol; 1996 Mar; 51(6):737-42. PubMed ID: 8602868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
    Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
    Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.
    Kohler C; Carroll M; Tarrant E; Torley L; Wissner A
    Inflammation; 1993 Jun; 17(3):245-61. PubMed ID: 8330926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.
    Benveniste J; Chignard M; Le Couedic JP; Vargaftig BB
    Thromb Res; 1982 Mar; 25(5):375-85. PubMed ID: 6803388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet secretory phospholipase A2 fails to induce rabbit platelet activation and to release arachidonic acid in contrast with venom phospholipases A2.
    Mounier C; Vargaftig BB; Franken PA; Verheij HM; Bon C; Touqui L
    Biochim Biophys Acta; 1994 Aug; 1214(1):88-96. PubMed ID: 8068732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of secretory phospholipase A2. 1-design, synthesis and structure-activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLA2s.
    Assogba L; Ahamada-Himidi A; Habich NM; Aoun D; Boukli L; Massicot F; Mounier CM; Huet J; Lamouri A; Ombetta JE; Godfroid JJ; Dong CZ; Heymans F
    Eur J Med Chem; 2005 Sep; 40(9):850-61. PubMed ID: 16084626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of phospholipase A2 complex with the hydrolysis products of platelet activating factor: equilibrium binding of fatty acid and lysophospholipid-ether at the active site may be mutually exclusive.
    Pan YH; Yu BZ; Berg OG; Jain MK; Bahnson BJ
    Biochemistry; 2002 Dec; 41(50):14790-800. PubMed ID: 12475227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive inhibition of lipolytic enzymes. VI. Inhibition of two human phospholipases A2 by acylamino phospholipid analogues.
    van den Berg L; Franken PA; Verheij HM; Dijkman R; de Haas GH
    Biochim Biophys Acta; 1992 Feb; 1124(1):66-70. PubMed ID: 1543727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2.
    Lindahl M; Tagesson C
    Inflammation; 1997 Jun; 21(3):347-56. PubMed ID: 9246576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
    Ribaldi E; Mezzasoma AM; Francescangeli E; Prosdocimi M; Nenci GG; Goracci G; Gresele P
    Br J Pharmacol; 1996 Jul; 118(6):1351-8. PubMed ID: 8832056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.
    Sadashiva MP; Nataraju A; Mallesha H; Rajesh R; Vishwanath BS; Rangappa KS
    Int J Mol Med; 2005 Nov; 16(5):895-904. PubMed ID: 16211261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
    Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
    Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of (4-acylpyrrol-2-yl)alkanoic acids as inhibitors of the cytosolic phospholipase A2: variation of the substituents in positions 1, 3, and 5.
    Lehr M
    J Med Chem; 1997 Oct; 40(21):3381-92. PubMed ID: 9341913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of lipidic amino acid and dipeptide inhibitors of human platelet phospholipase A2.
    Kokotos G; Constantinou-Kokotou V; Noula C; Nicolaou A; Gibbons WA
    Int J Pept Protein Res; 1996 Aug; 48(2):160-6. PubMed ID: 8872534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells.
    Kell PJ; Creer MH; Crown KN; Wirsig K; McHowat J
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1163-70. PubMed ID: 14560038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respective roles of the 14 kDa and 85 kDa phospholipase A2 enzymes in human monocyte eicosanoid formation.
    Marshall LA; Bolognese B; Roshak A
    Adv Exp Med Biol; 1999; 469():215-9. PubMed ID: 10667333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation.
    Mounier C; Hatmi M; Faili A; Bon C; Vargaftig BB
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1460-7. PubMed ID: 8450479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.